• Policy
• Will it be possible to expand the benefit of Prolia?
• by Lee, Jeong-Hwan Sep 10, 2021 05:58am

• Company
• Medytox’s American dream falters with returned botox rights
• by Kim, Jin-Gu Sep 9, 2021 05:55am

• Policy
• A bill to revise some of the Jeju Special Law
• by Lee, Jeong-Hwan Sep 9, 2021 05:55am

• Company
• Genome & Co acquires US firm to enter CDMO business
• by An, Kyung-Jin Sep 9, 2021 05:55am

• Company
• Leclaza can be prescribed at general hospitals
• by An, Kyung-Jin Sep 9, 2021 05:54am

• Company
• Alunbrig proves the effectiveness of epilepsy patients
• by Sep 9, 2021 05:54am

• Company
• It would have been a big trouble if no improvement
• by Chon, Seung-Hyun Sep 8, 2021 06:07am

• Opinion
• Clear standards needed for direct purchase of drugs overseas
• by Kim JiEun Sep 8, 2021 06:06am

• Policy
• Proposal of a bill to abolish special cases for Jeju
• by Lee, Jeong-Hwan Sep 8, 2021 06:05am

• Policy
• 3 companies voluntarily recall varenicline products
• by Lee, Jeong-Hwan Sep 8, 2021 06:05am